A pharmacist-led Medicare Medication Therapy Management program can improve clinical outcomes in Medicare beneficiaries without an increase in medication costs.
Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.
Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.
This article analyzes use of lumbar spine magnetic resonance imaging in a national sample of patients with low back pain.
A coinsurance rate decrease can result in increased adherence to oral antihyperglycemic agents and improved clinical outcomes and cost savings for the healthcare system.
Health insurance plan type may be an important lever for reducing low-value healthcare use among patients with commercial insurance.
This study characterized patterns and costs of medical care by disease phase in patients with newly diagnosed mCRC using a large US national commercially insured claims database.
Management of high and rising costs in oncology requires a multifaceted approach using both innovative strategies and pragmatic tools. In this article, we discuss several factors that influence the costs of oncology care.
Using a seamlessly shared inpatient-outpatient electronic health record was associated with greater rates of postdischarge follow-up delivered through telemedicine or laboratory monitoring and without an in-person office visit.
Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.
A new study adds to the evidence that financial pressure, or the perception of pressure, may keep patients from getting treatment or taking medication for chronic conditions such as hypertension.
Selected abstracts from the 2019 Annual Meeting of the American Society of Clinical Oncology.
This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
Looking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.
This study examined the impact of the Medicare Part D coverage gap on medication use by Hispanics, blacks, and whites with diabetes.
Pneumococcal; tetanus, diphtheria, and pertussis; and influenza vaccination increased among high-risk adults in a 2-year study.